Tuesday 20 November 2018
Home      All news      Contact us     
cnbc.com - 1 month ago

Roche posts modest third-quarter sales beat as new drugs offset biosimilar hit

Roche s third-quarter sales rose 7 percent, above analyst forecasts, as sales of new drugs including its multiple sclerosis therapy Ocrevus helped offset the impact that rivals copies are having on the Swiss group s top-selling drugs.

Related news

Latest News
Hashtags:   

Roche

 | 

posts

 | 

modest

 | 

third

 | 

quarter

 | 

sales

 | 

drugs

 | 

offset

 | 

biosimilar

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources